Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| SCLX | PRESS-RELEASE | neutral | 2/10 | Scilex Holding Company confirmed the payment date of June 15, 2026 for its previously announced dividend of Semnur Pharm | Jun 12, 2026 |
| KSPI | PRESS-RELEASE | neutral | 3/10 | Kaspi.kz shareholders approved a share buyback program at the EGM on June 11, 2026. The press release provides no financ | Jun 12, 2026 |
| FRVO | PRESS-RELEASE | neutral | 1/10 | Fervo Energy Company announced it will report its Q1 2026 results on June 22, 2026. | Jun 12, 2026 |
| BCRX | PRESS-RELEASE | neutral | 4/10 | BioCryst presented updated clinical data at EAACI 2026, including 48-week ORLADEYO pediatric results showing sustained H | Jun 12, 2026 |
| KYMR | PRESS-RELEASE | neutral | 3/10 | Kymera presented Phase 1 data for KT-621 (oral STAT6 degrader) in healthy Japanese adults at the JDA Annual Meeting, sho | Jun 12, 2026 |
| MBX | PRESS-RELEASE | bullish | 6/10 | MBX Biosciences announced full Phase 2 and one-year open-label extension data for canvuparatide in hypoparathyroidism, s | Jun 12, 2026 |
| JFIN | PRESS-RELEASE | neutral | 1/10 | Jiayin Group Inc. announced it will report its Q1 2026 results on June 23, 2026. | Jun 12, 2026 |
| JG | PRESS-RELEASE | neutral | 3/10 | MoonFox Data (JG) reported Q1 2026 EPS of $0.27, in line with consensus, but the press release focuses on iQIYI's financ | Jun 12, 2026 |
| AUTL | PRESS-RELEASE | neutral | 3/10 | Autolus Therapeutics received the 2026 Prix Galien UK Award for Best Biotechnology Product, a prestigious industry recog | Jun 12, 2026 |
| EVAX | PRESS-RELEASE | neutral | 3/10 | Evaxion receives the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology platform. While th | Jun 12, 2026 |
| SWKS | PRESS-RELEASE | neutral | 4/10 | Skyworks provided an update on its exchange offers for Qorvo's outstanding senior notes, reporting high tender participa | Jun 11, 2026 |
| RKDA | PRESS-RELEASE | bearish | 7/10 | Arcadia Biosciences announces a private placement of ~3.88M common shares (or pre-funded warrants) plus two series of pr | Jun 11, 2026 |
| NDAQ | PRESS-RELEASE | neutral | 2/10 | Nasdaq announced the June 2026 quarterly rebalance of the Nasdaq-100 Index, adding five companies (Astera Labs, CoreWeav | Jun 11, 2026 |
| HCM | PRESS-RELEASE | bullish | 7/10 | HUTCHMED announced positive Phase 3 results for sovleplenib in warm AIHA (wAIHA), showing a 66% durable response rate vs | Jun 11, 2026 |
| PNRG | PRESS-RELEASE | neutral | 3/10 | PrimeEnergy held its annual shareholder meeting on June 10, 2026, re-electing five directors and authorizing the repurch | Jun 11, 2026 |
| CLBK | PRESS-RELEASE | neutral | 5/10 | Columbia Financial has mailed election forms to Northfield Bancorp stockholders, allowing them to choose between stock a | Jun 11, 2026 |
| VNO | PRESS-RELEASE | bullish | 6/10 | Vornado Realty Trust completed its acquisition of a 49% interest in Park Avenue Plaza at a gross valuation of $1.1 billi | Jun 11, 2026 |
| MTH | PRESS-RELEASE | neutral | 1/10 | Meritage Homes Corporation announced it will host a conference call on July 30, 2026 to discuss its Q2 2026 results. | Jun 11, 2026 |
| DSGX | PRESS-RELEASE | bearish | 6/10 | Descartes Systems Group reported Q1 FY2027 EPS of $0.55, a 20.3% miss vs the $0.69 consensus estimate. The filing is an | Jun 11, 2026 |
| WFRD | PRESS-RELEASE | mixed | 5/10 | Weatherford's shareholder meetings failed to approve the proposed redomestication from Ireland to Texas, with over 60% s | Jun 11, 2026 |
| EOSE | PRESS-RELEASE | bearish | 6/10 | Eos Energy Enterprises announced a rights offering to fund its capital contribution in the Frontier Power USA joint vent | Jun 11, 2026 |
| NNOX | PRESS-RELEASE | neutral | 1/10 | Nano-X Imaging Ltd announced it will report its Q1 2026 results on June 25, 2026. | Jun 11, 2026 |
| MDLZ | PRESS-RELEASE | neutral | 2/10 | Mondelez International released its 2025 Human Rights Due Diligence and Modern Slavery Report, highlighting progress on | Jun 11, 2026 |
| ADIL | PRESS-RELEASE | bullish | 7/10 | Adial Pharmaceuticals acquires Azora Therapeutics and secures up to $64M in private placement, pivoting to a colon-targe | Jun 11, 2026 |
| PROP | PRESS-RELEASE | mixed | 5/10 | Prairie Operating Co. reaffirmed its $475M borrowing base and amended its Series F preferred stock agreement to extend t | Jun 11, 2026 |
| CRBU | PRESS-RELEASE | bullish | 7/10 | Caribou Biosciences reported longer follow-up data from the CaMMouflage Phase 1 trial of CB-011, an off-the-shelf BCMA-t | Jun 11, 2026 |
| TOVX | PRESS-RELEASE | bullish | 7/10 | Theriva Biologics announced publication of Phase 1 trial results for VCN-01 in immunotherapy-refractory HNSCC in Clinica | Jun 11, 2026 |
| SNDX | PRESS-RELEASE | bullish | 7/10 | Syndax presented 12 abstracts on revumenib at EHA 2026, including real-world data showing 82% ORR in R/R NPM1m/KMT2Ar pa | Jun 11, 2026 |
| LOVE | PRESS-RELEASE | bearish | 5/10 | Lovesac reported Q1 FY27 net sales of $138.2M, essentially flat YoY (-0.1%), and a GAAP net loss of $0.76 per share, sli | Jun 11, 2026 |
| CCCC | PRESS-RELEASE | bullish | 6/10 | C4 Therapeutics presented updated Phase 1 data for cemsidomide at EHA 2026, showing a 53% overall response rate at the 1 | Jun 11, 2026 |